Health and Human Services Secretary Robert F. Kennedy Jr. is traveling across several U.S. states to support Republican candidates ahead of the upcoming midterm elections. The White House stated the travel aims to mobilize voters through the "Make America Healthy Again" (MAHA) platform, which focuses on fitness, chronic disease, and food safety. During a recent week of travel, Kennedy visited Iowa, Nebraska, and Minnesota to hold events with GOP candidates, including Iowa gubernatorial candidate Zach Lahn.
President Donald Trump appointed Kennedy, a former Democrat and vaccine critic, to lead the Health Department last year. The administration has since sought to leverage Kennedy’s popularity with independent and health-focused voters. However, some activists within the MAHA movement have expressed concern that the administration is prioritizing Kennedy’s role as a campaigner over his ability to implement specific policy goals, such as stricter regulations on pesticides and vaccines.
Recent personnel decisions have become a point of contention for some movement supporters. President Trump recently nominated Heidi Overton, a White House aide, to lead the Food and Drug Administration (FDA). Some MAHA activists criticized the pick due to Overton's involvement in an executive order protecting the production of glyphosate, an herbicide linked to cancer. Additionally, the recently confirmed head of the Centers for Disease Control and Prevention (CDC), Erica Schwartz, has stated that vaccines are safe and effective, a position that differs from Kennedy’s previous pledges to reduce the childhood vaccine schedule.
For consumers and small-business owners in the food industry, the administration's policy moves involve new reporting requirements for food additives. While Kennedy has advocated for a ban on ultra-processed foods and European-style labeling, the FDA has instead proposed a system where companies disclose new ingredients voluntarily. This affects the production and labeling of thousands of grocery store products. Meanwhile, farmers and agricultural workers are affected by the administration's decision in February to protect the production of glyphosate, a multibillion-dollar herbicide industry, despite Kennedy's stated goals of reducing chemical use in the food supply.
The outcome of these policy disagreements will define the regulatory environment for the pharmaceutical and agricultural sectors through the end of the current presidential term. If the courts uphold challenges to the modified vaccine schedule, federal health agencies will remain at an impasse with the executive branch's stated goals. Voters in competitive districts, such as those Kennedy visited in Omaha and Des Moines, will see the impact of these health platforms in their local campaigns as the midterm elections approach. A ruling on the vaccine schedule lawsuit is pending in federal court, and the FDA's new ingredient disclosure proposal is currently under review.